Deep Track Capital, LP - 30 Sep 2025 SCHEDULE 13G Report for Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share (AKRO)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
AKRO
Shares outstanding
80,000,000 shares
Disclosed Ownership
4,400,000 shares
Ownership
5.5%
Form type
SCHEDULE 13G
Filing time
07 Oct 2025, 16:34:29 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 5.5% 4,400,000 0 4,400,000 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.5% 4,400,000 0 4,400,000 /s/ David Kroin David Kroin, Director
David Kroin 5.5% 4,400,000 0 4,400,000 /s/ David Kroin David Kroin